The study was reviewed by the institutional ethics committee and approved as a clinical audit. In accordance with local policy, informed consent was not required. Patients were included if they had undergone MRI-directed targeted TRUS-guided anterior prostate biopsy in 2011–2014 because of suspicion of anterior tumor on MRI (Chart 1). All patients had undergone previous nontargeted TRUS-guided sectoral biopsy which was negative for carcinoma, but had undergone MRI for further evaluation due to persistent clinical concern for occult neoplasm.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.